Brief: Fortress Biotech Announces Pricing Of $11 Million Registered Direct Offering
29/12/2023 13:43
Dec 29 (Reuters) - Fortress Biotech Inc FBIO.O :
* FORTRESS BIOTECH ANNOUNCES PRICING OF $11 MILLION
REGISTERED
DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES
Source text for Eikon: ID:nGNX9v8fdF
Further company coverage: FBIO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fortress Biotech
See all newsFortress Biotech Inc reports results for the quarter ended June 30 - Earnings Summary
Fortress Biotech Inc expected to post a loss of 20 cents a share - Earnings Preview
Brief: Fortress Biotech And Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $130 Million Series B Financing
Fortress Biotech Q1 net income jumps on PRV sale
Brief: Journey Medical Corporation Secures Contract With Third Major Gpo For Emrosi